Literature DB >> 30266365

Management of Heart Failure in Adult Congenital Heart Disease.

Aarthi Sabanayagam1, Omer Cavus2, Jordan Williams2, Elisa Bradley3.   

Abstract

There are more than 1 million adults with congenital heart disease (ACHD) in the United States. Heart failure (HF) is the most common late cardiovascular complication. These patients are challenging to manage given their diverse presentation, anatomy, and complex hemodynamics. Examination of underlying anatomy is crucial because many require late transcatheter and surgical interventions after developing HF. Management of arrhythmia is equally important because this can modify HF symptoms. A multidisciplinary team with expertise in the care of ACHD-HF is critical.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital heart disease; Fontan; Heart failure; Single ventricle dysfunction; Systemic ventricle dysfunction

Mesh:

Year:  2018        PMID: 30266365      PMCID: PMC6204213          DOI: 10.1016/j.hfc.2018.06.005

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  68 in total

Review 1.  Transcriptional pathways in second heart field development.

Authors:  Brian L Black
Journal:  Semin Cell Dev Biol       Date:  2007-01-17       Impact factor: 7.727

2.  Enalapril does not enhance exercise capacity in patients after Fontan procedure.

Authors:  A A Kouatli; J A Garcia; T M Zellers; E M Weinstein; L Mahony
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

3.  Effectiveness of Early Invasive Therapy for Atrial Tachycardia in Adult Atrial-Baffle Survivors.

Authors:  Elisa A Bradley; Ali N Zaidi; Justin Morrison; Curt J Daniels; Steven Kalbfleisch; Naomi J Kertesz
Journal:  Tex Heart Inst J       Date:  2017-02-01

4.  Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.

Authors:  Judith Therrien; Yves Provost; Jeanine Harrison; Michael Connelly; Harald Kaemmerer; Garry D Webb
Journal:  Int J Cardiol       Date:  2008-07-30       Impact factor: 4.164

5.  Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.

Authors:  Mark J Schuuring; Jeroen C Vis; Arie P J van Dijk; Joost P van Melle; Hubert W Vliegen; Petronella G Pieper; Gertjan T Sieswerda; Rianne H A C M de Bruin-Bon; Barbara J M Mulder; Berto J Bouma
Journal:  Eur J Heart Fail       Date:  2013-01-29       Impact factor: 15.534

6.  Isolated heart transplant and combined heart-liver transplant in adult congenital heart disease patients: Insights from the united network of organ sharing.

Authors:  Elisa A Bradley; Krong-On Pinyoluksana; Melissa Moore-Clingenpeel; Yongjie Miao; Curt Daniels
Journal:  Int J Cardiol       Date:  2016-11-10       Impact factor: 4.164

7.  Survival with congenital heart disease and need for follow up in adult life.

Authors:  C Wren; J J O'Sullivan
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 8.  Congenital heart disease: the original heart failure syndrome.

Authors:  Aidan P Bolger; Andrew J S Coats; Michael A Gatzoulis
Journal:  Eur Heart J       Date:  2003-05       Impact factor: 29.983

9.  Impact of spironolactone on endothelial function in patients with single ventricle heart.

Authors:  William T Mahle; Alicia Wang; Arshed A Quyyumi; Michael E McConnell; Wendy M Book
Journal:  Congenit Heart Dis       Date:  2009 Jan-Feb       Impact factor: 2.007

10.  Eplerenone in systemic right ventricle: double blind randomized clinical trial. The evedes study.

Authors:  Laura Dos; Sandra Pujadas; Montserrat Estruch; Assumpta Mas; Ignacio Ferreira-González; Antònia Pijuan; Ricard Serra; Jordi Ordóñez-Llanos; Maite Subirana; Guillem Pons-Lladó; Josep R Marsal; David García-Dorado; Jaume Casaldàliga
Journal:  Int J Cardiol       Date:  2013-07-25       Impact factor: 4.164

View more
  4 in total

1.  Clinical Outcomes During Admissions for Heart Failure Among Adults With Congenital Heart Disease.

Authors:  Anushree Agarwal; Carson W Dudley; Gregory Nah; Robert Hayward; Zian H Tseng
Journal:  J Am Heart Assoc       Date:  2019-08-17       Impact factor: 5.501

Review 2.  Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.

Authors:  Carlos Daniel Varela-Chinchilla; Daniela Edith Sánchez-Mejía; Plinio A Trinidad-Calderón
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-26

3.  Systemic ventricular strain and torsion are predictive of elevated serum NT-proBNP in Fontan patients: a magnetic resonance study.

Authors:  Li-Wei Hu; Xin-Rong Liu; Qian Wang; Gregory P Barton; Rong-Zhen Ouyang; Ai-Min Sun; Chen Guo; Tong-Tong Han; Xiao-Fen Yao; Christopher J François; Yu-Min Zhong
Journal:  Quant Imaging Med Surg       Date:  2020-02

4.  The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis.

Authors:  Chaojun Yang; Zhixing Fan; Jinchun Wu; Jing Zhang; Wei Zhang; Jian Yang; Jun Yang
Journal:  Front Cardiovasc Med       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.